The Biotech Casino Strikes Again As ARCA Biopharma Inc Surges 230%

Looking for a kick arse rate of return today? Well it’s too late to hop on the gravy train known as ARCA biopharma Inc (ABIO).

The stock is up 230% after the US Patent Office approved an ARCA patent attributed to treating heart failure.

ABIO 220 per cent

Photo: FinViz

Business Insider Emails & Alerts

Site highlights each day to your inbox.

Follow Business Insider Australia on Facebook, Twitter, LinkedIn, and Instagram.